<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04208126</url>
  </required_header>
  <id_info>
    <org_study_id>ELIEO</org_study_id>
    <nct_id>NCT04208126</nct_id>
  </id_info>
  <brief_title>Early Versus Late Initiation of ECMO (Extracorporal Membrane Oxygenation) Trial (ELIEO-Trial)</brief_title>
  <acronym>ELIEO</acronym>
  <official_title>Early Versus Late Initiation of ECMO Trial (ELIEO-Trial)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Tuebingen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Tuebingen</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial is a prospective randomized multicenter trial that assigns patients to either a&#xD;
      treatment for Acute Respiratory Distress Syndrome (ARDS) with an Extracorporal Membrane&#xD;
      Oxygenation (ECMO) immediately after admission to the intensive care unit or conservative&#xD;
      treatment. The later can undergo ECMO following failure of conservative therapy as a rescue&#xD;
      therapy. Patients will be included within 96h of the onset of symptoms of ARDS and will be&#xD;
      randomized according to standard procedure. Follow-up will be performed until hospital&#xD;
      discharge.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients suffering acute ARDS defined according to the Berlin Definition starting from severe&#xD;
      stage with acute onset and (i) ratio partial arterial pressure of oxygen fraction of inspired&#xD;
      oxygen inspired oxygen fraction (PaO2/ FiO2) ≤ 200 (ii) Bilateral opacities consistent with&#xD;
      pulmonary edema on frontal chest radiograph, and (iii) requirement for positive pressure&#xD;
      ventilation via an endotracheal tube or non-invasive ventilation (iv) no clinical evidence of&#xD;
      left atrial hypertension, or if measured, a Pulmonary Arterial Wedge Pressure (PAOP) less&#xD;
      than or equal to 18 mm Hg will be treated by ECMO either within 24 hours to referral to an&#xD;
      ARDS ECMO center or as rescue therapy after failure of conventional therapy.&#xD;
&#xD;
      Outcome measures have been chosen according to robustness and sensitivity to change. They are&#xD;
      of high clinical impact and reflect the treatment effect desired by clinicians. Primary&#xD;
      efficacy endpoint: All cause mortality by 28-days. Key secondary endpoints are: 1) 90 day all&#xD;
      cause mortality 3) ICU length of stay 4) duration of mechanical ventilation support 5)&#xD;
      frequency and duration of renal replacement therapy 6) bleeding requiring transfusions in the&#xD;
      ICU 7) SOFA score&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2021</start_date>
  <completion_date type="Anticipated">October 1, 2024</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>This trial is a prospective randomized multicenter trial that assigns patients to either a treatment for ARDS with an ECMO immediately after admission to the intensive care unit or conservative treatment.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>28 day all cause mortality</measure>
    <time_frame>28 day after study inclusion</time_frame>
    <description>28 day all cause mortality</description>
  </primary_outcome>
  <primary_outcome>
    <measure>90 day all cause mortality</measure>
    <time_frame>90 day after study inclusion</time_frame>
    <description>90 day all cause mortality</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sepsis-related organ failure assessment score (SOFA) Organ Failure Scores</measure>
    <time_frame>1-14, 28 and 90 days after study inclusion</time_frame>
    <description>SOFA Organ Failure Scores</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Delirium</measure>
    <time_frame>28 and 90 day after discharge of ICU</time_frame>
    <description>Occurence of Delirium (positive Confusion Assessment Method for the Intensive Care Unit (CAM-ICU))</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>discharge location</measure>
    <time_frame>28 and 90 day after discharge of ICU</time_frame>
    <description>discharge location: a) home, b) skilled nursing facility, c) rehabilitation unit</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Acute Respiratory Distress Syndrome</condition>
  <arm_group>
    <arm_group_label>Early ECMO</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>ECMO is placed immediately after admission to the intensive care unit</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Conservative therapy unless failure of therapy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ECMO</intervention_name>
    <description>ECMO implantation immediately after ICU admission</description>
    <arm_group_label>Early ECMO</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ARDS as defined according to the Berlin Definition1&#xD;
&#xD;
          -  The term &quot;acute onset&quot; is defined as follow: the duration of the hypoxemia criterion&#xD;
             and the chest radiograph criterion must be ≤ 7 days at the time of randomization.&#xD;
&#xD;
          -  Patients must be enrolled within 96 hours of onset of ARDS and no later than 7 days&#xD;
             from the initiation of mechanical ventilation.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age less than 18 years&#xD;
&#xD;
          -  More than 7 days since initiation of mechanical ventilation&#xD;
&#xD;
          -  more than 96 hours since meeting inclusion criteria&#xD;
&#xD;
          -  patient, surrogate or physician not committed to full intensive care support&#xD;
&#xD;
          -  pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>December 5, 2019</study_first_submitted>
  <study_first_submitted_qc>December 19, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 23, 2019</study_first_posted>
  <last_update_submitted>August 31, 2021</last_update_submitted>
  <last_update_submitted_qc>August 31, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Acute Respiratory Distress Syndrome</keyword>
  <keyword>Extracorporal membrane Oxygenation</keyword>
  <keyword>Outcome</keyword>
  <keyword>Ventilation Therapy</keyword>
  <keyword>QOL</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Distress Syndrome</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Acute Lung Injury</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

